ºÝºÝߣ

fda qbd pat quality assurance quality us fda quality by design pharmaceuticals pharmaceutical cgmp professional development gmp biosimilars design development system cmc culture india maturity generics nipte systems thinking therapeutic equivalence risk integrity data validation ich q10 fda cder order of conciousness quality control generic drugs warning letters data integrity continued process verificaiton usa continulal professional development ich q8 voice of patients qms behavior 21st century cures act experience pharmaceutical equivalence professional bioequivalence placebo good process import alert ema evidence complex manufacturing office of pharmaceutical quality real world adult human develoment complexity science conciousness continuous improvement chaos continuous manufactruing inspection industry 4.0 uncertainty compliance form 483 patients regulatory science practices usp systems confidence ich q9 control substitution internal validation interchangeability affordability smart technology biotechnology practice statistical managment pharmaceutical technology vaccine nocebo self-authored leadership external validaiton management assurance fda qbd gmp cmc review inspection metrics design r human equivalence irrational expectation dissolution pharmaceutical engineering engineering education methylphenidate behavioral economics adhd warning letter cheating value breaches big data china user experience ai hussain excipients quality management system biases knowledge managment education and training regulation pharmacy review design thinking pharmaceutical industry industry experience economy orders of conciousness ich nist pharma 4.0 challenges pay for performacne customer experience concerta adhearance recalls therapeutic statistics sameness patient safety knowledge risk management cognitive drug regulation formulation sciences cmc review uncertinty manufactruing usa cost of drugs supply chain insight culture of pharmaceutical quality q10 subject by formulation generic regualtion pharmacist emotions oos invalidated oos rate training expereince certification one quality voice expereince economy satisfaction matruity blind-spots gcp fractals glp personalized measurement calibrator eu capability controls quantity ajaz hussain errors medicine common cause qualia nanotechnology professionaljourney efficacy safety comparability inspections regulatory uncertainty understanding voice pat cppr nipte desing bcs inequality continuous ajaz drug shortages knowledge management community of knowledge question based development regulatory communication thinking by desing process validaiton new prior knowledge response similarity regulations target row profile innovation logic educating drug utilisation next generation communication university pharmacokinetics and pharmacodynamics drug discovery 2014 classification biopharmaceutics collaboration team econometrics organizational chemometrics blind norms pharmacometrics poor reliability perception pharmacopoeias cluster drugs devices attitude preventive factors epa quality-by-design careing gauge r&r integrative thniking fraud keystone disorder lack of effect habits tablet testing pragmatic implementation system. pharmacokinetics ab rating patient attention deficit interchangeeability risk managment pharmaceutics complaints intention opq specifications haikudeck malaria economics argumentation integrative thinking daniel kahneman opportunities amos tversky breakthrough therapy designation failure panjab predictive oration trial and error biowaiver food & drug administration pat team exposure mechanistic biomarkers q9 q8 q12 q11 interaction cancer real time release replicate complinace heparin behaviour tablets counterfeits consciously econometric fear subconscious biosimilar fdasia smartphones smartfactory sustainability good practices #validaiton #practices #good #gmp #glp #gcp #maturity #development #suitability #capability #regualtion #control #lifecycle #lifespiral #laws #orders #self-authership #quality #assurance evil immaturity post-truth aloca suitability contol consciousness pharmaceutical engineering science covid19 theraputics repurposing weight of evidence totality of evidence residual uncertainty r malcom baldridge award qulaity new drugs aaps cphi 2020 orders of consciousness doe faculty best practices 21st century ich 14 supac professional journey borg emergent monoclonal antibodies fda thai streamline advanced analytics charecterization shepherding expected intelligence artifical natural meanning common sense fd&c act continual improvment regualtions human 4.0 ml llm formulation profession matrutity observations warning lettr cpv life-cycle chatgpt law mandates cognative interest audit adulthood desing conciousess validaiton pharma 4 industry 4 revolution mangement dscsa serialization generic drug theraputic resilience intution instiution regulator sfda concionsness care health pharmacy to the world change management cmo tipping point elephant in the dark angle of repose six blind men and the elephant rumi snakes and ladders bioequivalence generic nasal sprary crtitical path niimbl president-elect transformation trump quality of drugs ajaz s. hussain advice part 11 software makeing in america globalization process analytical technology email marketing interchnageability happiness selfconfidence socialized mind generic< medicine quaity equivance eurpoe pharma 483 violations emerging economies canada health canada price pressure epistemic trust gdufa qbr integrated six sigma passion persistance who mhra anda defaults nda bla patheon qbd. 21st century rumination emotional processing levothyroxine brand drugs theraputic equivalence ifpac excipientes certificaiton information technology wisdom pqri personal harm reduction vaping smoking mrtp clinical trials leadership development ich q12 ich q11 inactive ingredient guide constructive development theory quality system omission comission special cause capa real-time controls metrics badi alcoa adpharming msc industrial engineering branding biotech chemical emotional inteligence adult development deming theory of knowledge epistemology product withdrawals import alerts process validation availability comlexity one voice ecology efficiency income outcome lifecycle remediaiton